CONECTA
montai.com
5.6 Club score Visit montai.com
What the maker publishes
- Biology-first discovery
- The platform uses a biology-first, mechanism-agnostic approach to match chemistry to desired disease activity profiles. source
- Candidate timeline
- Montai says it can advance hits to potent and selective oral candidates in approximately 24 months. source
- Chemical library
- Montai says its curated chemical space contains more than 3 billion unique compounds. source
- Complex targets
- The platform seeks drug discovery solutions for complex protein targets, including those with no known binding pockets. source
- Data and pathways
- Its multimodal foundation models are trained on more than 1 billion curated and proprietary data points and over 100 biological pathways across five therapeutic areas. source
- Founded
- 2019 source
- Headquarters
- Cambridge, Massachusetts, United States source
- Headquarters
- Montai Therapeutics is headquartered at 26 Landsdowne Street, Cambridge, Massachusetts 02139. source
- Hit rate claim
- Montai reports an 80-fold higher hit rate than traditional drug screening and ninefold higher than public machine-learning models. source
- Integrated expertise
- The platform brings together biologists, chemists, toxicologists, CMC experts, drug developers, and machine-learning experts. source
- Intended users
- The platform is described as empowering drug developers to find oral solutions for difficult biology in chronic inflammatory disease. source
- Partnership inquiries
- Montai invites partnership inquiries by email. source
- Platform access
- Montai describes its website as an informational resource about the platform, rather than presenting it as a downloadable software product. source
- Predictive models
- The platform includes more than 60 drug-property models. source
- Privacy contact
- Montai lists [email protected] for privacy questions and requests. source
- Purpose
- CONECTA is an AI-powered drug discovery platform designed to turn underexplored natural chemistry into oral therapies. source
- Scaffolds
- Montai reports that 99% of its Anthromolecule library scaffolds are unique. source
Checked against the maker's pages on 14 Nov 2026.